|
Post–authorizacion study on safety in sentinel sites in adult patients with chronic kidney disease undergoing dialysis |
|
Anti-PD-1 2C12 in patients with Hodgkin lymphoma. HOPE 2C12 Study |
|
Expanded clinical use of NeuralCIM in mild to moderate Alzheimer's disease (REAL study) |
|
Effect of Antibiotic Antidote for Microbiome Restoration |
|
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma |
|
Prevenox in menopausal women |
|
Oral OLEOZON® in the endodontic treatment of teeth with pulp necrosis. Phase II |
|
Evaluation of patients with a clinical diagnosis of the amnesic variant of Alzheimer´s disease phenotype without specific treatment. |
|
Anti-PD1 2C12 in patients with relapsed or refractory Hodgkin lymphoma |
|
Ozonized platelet-rich plasma and ozonized platelet-rich fibrin in temporomandibular osteoarthritis. Fase II |
|
Effect of continuous slow renal replacement therapies in the treatment of acute kidney injury in critically ill patients. |
|
Policosanol on cognitive impairment after ischemic stroke |
|
Effectiveness and Safety of Jusvinza in Patients with Chikungunya |
|
Growth hormone-releasing peptide in sepsis-induced myocardial dysfunction. |
|
Effectiveness of a multicomponent focalized hotspot targeted strategy to reduce dengue transmission |
|
Evaluation of the effect of the SymBiElle for vaginal health |
|
Policosanol in Coronary Artery Disease |
|
HeberNasvac in chronic hepatitis B viral infection in adult patients. Routine clinical practice study |
|
Efficacy and safety of CIMAvax-FOLFOX-BEVA in unresectable, left-sided, metastatic, colorectal cancer. Phase I/II |
|
Rectal ozone therapy in patients with joint symptoms following the acute phase of Chikungunya. |
